It was a real pleasure to be in the « High-Content and Phenotypic Screening » meeting in Cambridge. We were invited by our partner Molecular Devices to give a talk during the “User meeting Molecular Devices” about our vision of 3D culture in phenotypic screening and the impact of new technologies. We also presented a poster about “Neurotoxicity assay on 2D and 3D culture using High Content Screening technology”.

You can find our presentation here and our poster here.

It was a good opportunity to present our new laboratories in Lille and the future HCS Pharma robotic platform built by Molecular Devices with two ImageXpress Micro confocal.

After a short presentation of our services, we explained our implication in the two research projects InnovCell 3D and Chopin. Many people were interested by these programs,

We also shared again our uses of new technologies like augmented reality, virtual reality or machine learning, like in the previous forum LABO. We noticed that the 3D segmentation is a problem for almost everybody. It will be one of our goal for 2017 to check as many segmentation solutions as possible and to build our own in relation with MetaXpress and Molecular Devices.

If you have any questions, if you want to share about this topic, don’t hesitate to contact us !

Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.